Prostate cancer
Conditions
Interventions
Linear gold marker is buried in the connective tissue both side of the prostate at seed implantation. CT imaging is acquired just after seed implantation. One month after seed implantation, the planni
Sponsors
National Hospital Organization Saitama Hosipital
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1) Patients with intermediate/high risk group of localized prostate cancer to satisfy PSA>=10ng/ml or Gleason score>=7 or more than 34% positive biopsy core rate 2) Written informed consent must be obtained from patient
Exclusion criteria
Exclusion criteria: 1) Patients less than 5 years life expectancy 2) Patients with distant metastases 3) Patients with gold allergy 4) Patients whom radiation therapy is contraindicated 5) Patients with bleeding tendency (including anticoagulant therapy) 6) Patients with ascites, pleural effusion 7) Parients suspeted with skin, pleura, peritoneum infection 8) Parients suspeted with abscess, vascular disease 9) Patients who can not be ensured a safe puncture route 10) Patients who can not be transfused 11) Patients whom target site is confusing 12) Patients who are judged inappropriate for the clinical trial by doctors
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The relative position error between the position coordinate and the reference CT image of the prostate as an index of the linear gold marker | — |
Countries
Japan
Contacts
Public ContactTomoya Kaneda
National Hospital Organization Saitama Hosipital Radiology
Outcome results
None listed